MedTrace Logo

CAMS-G Group Therapy for Suicidal Veterans

NCT03682406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-04-21

No results posted yet for this study

Summary

The primary aim of this pilot study is to determine the feasibility and acceptability of CAMS-G. Our aim is to determine if CAMS-G is an effective treatment and whether it has the potential to be tested in a large-scale setting.

Conditions

  • Suicide and Self-harm

Interventions

BEHAVIORAL

CAMS-G

Group-based suicide-specific intervention based upon the Collaborative Assessment and Management of Suicidality.

Sponsors & Collaborators

  • Rocky Mountain MIRECC for Suicide Prevention

    collaborator UNKNOWN

  • Louisville VA Medical Center

    lead FED

Principal Investigators

  • Eleanor Lederer, MD · Louisville VAMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-12-28
Completion
2022-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03682406 on ClinicalTrials.gov